Found: 23
Select item for more details and to access through your institution.
Celgene Patient Support Services.
- Published in:
- Oncology Practice Management, 2019, p. 34
- Publication type:
- Article
Treatment-emergent mutations in myelodysplastic syndrome with del(5q) – lenalidomide related or disease-intrinsic clonal evolution?
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01027-5
- By:
- Publication type:
- Article
Clival Encephalocele and 5q15 Deletion:: A Case Report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 3, p. 1043, doi. 10.1172/JCI78789
- By:
- Publication type:
- Article
Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 1, p. 114, doi. 10.1111/bjh.18163
- By:
- Publication type:
- Article
Beyond morphology: to be or not to be an MDS.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 238, doi. 10.1111/bjh.17649
- By:
- Publication type:
- Article
Preclinical characterisation and development of a novel myelodysplastic syndrome‐derived cell line.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 415, doi. 10.1111/bjh.17372
- By:
- Publication type:
- Article
Balanced translocations in myelodysplastic syndromes (MDS) – an unrecognised MDS patient subgroup?
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. 141, doi. 10.1111/bjh.16641
- By:
- Publication type:
- Article
CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 2, p. 210, doi. 10.1111/bjh.13563
- By:
- Publication type:
- Article
L-Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q- syndrome in a TP53-independent way.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 4, p. 524, doi. 10.1111/bjh.13069
- By:
- Publication type:
- Article
Clinicopathological characteristics of myelodysplastic syndromes with del(5q) in Taiwan.
- Published in:
- Malaysian Journal of Pathology, 2023, v. 45, n. 3, p. 405
- By:
- Publication type:
- Article
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 12, p. 2683, doi. 10.3390/jcm10122683
- By:
- Publication type:
- Article
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 1, p. 78, doi. 10.1111/ejh.13067
- By:
- Publication type:
- Article
Benjamin Ebert wins the 2021 ASCI/Stanley J. Korsmeyer Award.
- Published in:
- 2021
- By:
- Publication type:
- Biography
Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 1, p. 127, doi. 10.1038/bmt.2014.223
- By:
- Publication type:
- Article
Hemophilia B in a female with intellectual disability caused by a deletion of Xq26.3q28 encompassing the F9.
- Published in:
- Molecular Genetics & Genomic Medicine, 2018, v. 6, n. 6, p. 1220, doi. 10.1002/mgg3.425
- By:
- Publication type:
- Article
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00724-3
- By:
- Publication type:
- Article
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 9, p. 1942, doi. 10.1038/leu.2015.49
- By:
- Publication type:
- Article
Utilisation des analogues de la thalidomide dans le traitement des hémopathies malignes.
- Published in:
- Hematologie, 2022, v. 28, n. 1, p. 55, doi. 10.1684/hma.2022.1718
- By:
- Publication type:
- Article
Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case Report.
- Published in:
- Tohoku Journal of Experimental Medicine, 2023, v. 259, n. 2, p. 113, doi. 10.1620/tjem.2022.J104
- By:
- Publication type:
- Article
Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.
- Published in:
- Mycoses, 2015, v. 58, n. 9, p. 565, doi. 10.1111/myc.12357
- By:
- Publication type:
- Article
APC -Related Phenotypes and Intellectual Disability in 5q Interstitial Deletions: A New Case and Review of the Literature.
- Published in:
- Genes, 2023, v. 14, n. 7, p. 1505, doi. 10.3390/genes14071505
- By:
- Publication type:
- Article